Gilat Insider Notice: 7,500 Ordinary Shares Proposed Sale via Oppenheimer

Rhea-AI Filing Summary

Gilat Satellite Networks Ltd (GILT) Form 144 notice reports a proposed sale of 7,500 ordinary shares by an insider through Oppenheimer & Co. Inc. on 08/21/2025. The shares have an aggregate market value of $66,750 against approximately 57,017,032 shares outstanding, indicating this sale represents a very small fraction of the company.

The securities were acquired on 08/07/2023 under an employee stock option plan and will be paid in cash upon exercise. The filer certifies no undisclosed material adverse information; no other sales in the prior three months were reported.

Insights

Securities Analyst

TL;DR Insider plans to sell a small block of shares from an option exercise; impact on market and ownership is negligible.

The proposed sale of 7,500 shares valued at $66,750 is immaterial relative to the reported 57.0 million shares outstanding, representing roughly 0.013% of the float. The shares were acquired via an employee stock option plan and the sale is routed through a broker, consistent with routine insider liquidity events. There are no reported prior sales in the last three months and the filer affirms no undisclosed material information, which supports a neutral interpretation for investors.

Corporate Governance Expert

TL;DR Disclosure follows Rule 144 format; transaction appears routine and compliant with insider trading protocols.

The filing documents the acquisition date, nature of acquisition (employee stock option plan), planned broker-assisted sale, and certification about material information. This aligns with standard compliance practices for insider disposals under Rule 144. Absent additional context such as larger concurrent insider sales or unusual timing, the filing does not raise governance concerns but should be tracked as part of ongoing insider activity monitoring.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Ordinary	Oppenheimer & Co. Inc. 85 Broad St. New York NY 10004	7500	66750.00	57017032	08/21/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Ordinary	08/07/2023	Employee stock option plan	From the Issuer			7500	08/21/2025	Cash Upon Exercise

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the Form 144 for Gilat Satellite Networks (GILT) disclose?

The form discloses a proposed sale of 7,500 ordinary shares valued at $66,750, to be sold on 08/21/2025 via Oppenheimer & Co. Inc.

How were the shares in the GILT Form 144 acquired?

The shares were acquired on 08/07/2023 under an employee stock option plan and will be paid for in cash upon exercise.

Does the Form 144 report any other sales in the past three months?

No. The filing states "Nothing to Report" for securities sold during the past three months by the person for whose account the securities are to be sold.

What portion of Gilat's outstanding shares does this sale represent?

The filing lists 57,017,032 shares outstanding; the proposed sale of 7,500 shares is roughly 0.013% of that total.

Who is the broker handling the sale in the Form 144?

The broker named in the filing is Oppenheimer & Co. Inc., 85 Broad St., New York, NY 10004.